REPORT ID 13821

United States Liposomes Drug Delivery Market Report 2017

Publish Date
22-Nov-17
Pages
107
Format
Electronic (PDF)

In this report, the United States Liposomes Drug Delivery market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Liposomes Drug Delivery in these regions, from 2012 to 2022 (forecast).

United States Liposomes Drug Delivery market competition by top manufacturers/players, with Liposomes Drug Delivery sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Johnson & Johnson
    Gilead Sciences
    Luye Pharma
    Sun Pharmaceutical
    Pacira
    Fudan-Zhangjiang
    Sigma-Tau Group
    Teva Pharmaceutical
    CSPC
    Novartis
    Crucell
    Celsion Corporation
    Kingond Pharm
    Shanghai New Asia
    Spectrum Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Type I
    Type II
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Fungal Infection Therapy
    Cancer Therapy

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Liposomes Drug Delivery Market Report 2017
1 Liposomes Drug Delivery Overview
    1.1 Product Overview and Scope of Liposomes Drug Delivery
    1.2 Classification of Liposomes Drug Delivery by Product Category
        1.2.1 United States Liposomes Drug Delivery Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Liposomes Drug Delivery Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 
        1.2.4 
    1.3 United States Liposomes Drug Delivery Market by Application/End Users
        1.3.1 United States Liposomes Drug Delivery Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Fungal Infection Therapy
        1.3.3 Cancer Therapy
    1.4 United States Liposomes Drug Delivery Market by Region
        1.4.1 United States Liposomes Drug Delivery Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Liposomes Drug Delivery Status and Prospect (2012-2022)
        1.4.3 Southwest Liposomes Drug Delivery Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Liposomes Drug Delivery Status and Prospect (2012-2022)
        1.4.5 New England Liposomes Drug Delivery Status and Prospect (2012-2022)
        1.4.6 The South Liposomes Drug Delivery Status and Prospect (2012-2022)
        1.4.7 The Midwest Liposomes Drug Delivery Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Liposomes Drug Delivery (2012-2022)
        1.5.1 United States Liposomes Drug Delivery Sales and Growth Rate (2012-2022)
        1.5.2 United States Liposomes Drug Delivery Revenue and Growth Rate (2012-2022)

2 United States Liposomes Drug Delivery Market Competition by Players/Suppliers
    2.1 United States Liposomes Drug Delivery Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Liposomes Drug Delivery Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Liposomes Drug Delivery Average Price by Players/Suppliers (2012-2017)
    2.4 United States Liposomes Drug Delivery Market Competitive Situation and Trends
        2.4.1 United States Liposomes Drug Delivery Market Concentration Rate
        2.4.2 United States Liposomes Drug Delivery Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Liposomes Drug Delivery Manufacturing Base Distribution, Sales Area, Product Type

3 United States Liposomes Drug Delivery Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Liposomes Drug Delivery Sales and Market Share by Region (2012-2017)
    3.2 United States Liposomes Drug Delivery Revenue and Market Share by Region (2012-2017)
    3.3 United States Liposomes Drug Delivery Price by Region (2012-2017)

4 United States Liposomes Drug Delivery Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Liposomes Drug Delivery Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Liposomes Drug Delivery Revenue and Market Share by Type (2012-2017)
    4.3 United States Liposomes Drug Delivery Price by Type (2012-2017)
    4.4 United States Liposomes Drug Delivery Sales Growth Rate by Type (2012-2017)

5 United States Liposomes Drug Delivery Sales (Volume) by Application (2012-2017)
    5.1 United States Liposomes Drug Delivery Sales and Market Share by Application (2012-2017)
    5.2 United States Liposomes Drug Delivery Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Liposomes Drug Delivery Players/Suppliers Profiles and Sales Data
    6.1 Johnson & Johnson
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Liposomes Drug Delivery Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Johnson & Johnson Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Gilead Sciences
        6.2.2 Liposomes Drug Delivery Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Gilead Sciences Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Luye Pharma
        6.3.2 Liposomes Drug Delivery Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Luye Pharma Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Sun Pharmaceutical
        6.4.2 Liposomes Drug Delivery Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Sun Pharmaceutical Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Pacira
        6.5.2 Liposomes Drug Delivery Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Pacira Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Fudan-Zhangjiang
        6.6.2 Liposomes Drug Delivery Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Fudan-Zhangjiang Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Sigma-Tau Group
        6.7.2 Liposomes Drug Delivery Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Sigma-Tau Group Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Teva Pharmaceutical
        6.8.2 Liposomes Drug Delivery Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Teva Pharmaceutical Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 CSPC
        6.9.2 Liposomes Drug Delivery Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 CSPC Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Novartis
        6.10.2 Liposomes Drug Delivery Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Novartis Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Crucell
    6.12 Celsion Corporation
    6.13 Kingond Pharm
    6.14 Shanghai New Asia
    6.15 Spectrum Pharmaceuticals

7 Liposomes Drug Delivery Manufacturing Cost Analysis
    7.1 Liposomes Drug Delivery Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Liposomes Drug Delivery

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Liposomes Drug Delivery Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Liposomes Drug Delivery Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Liposomes Drug Delivery Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Liposomes Drug Delivery Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Liposomes Drug Delivery Sales Volume Forecast by Type (2017-2022)
    11.3 United States Liposomes Drug Delivery Sales Volume Forecast by Application (2017-2022)
    11.4 United States Liposomes Drug Delivery Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer